N-Butanoyl-L-homoserine lactone is a signaling-mimetic compound used in linker design for controlled release in ADCs. Its lactone ring structure introduces enzymatically cleavable characteristics, allowing selective payload release in tumor microenvironments and enhancing therapeutic specificity.
Structure of 67605-85-0
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
N-Butanoyl-L-homoserine lactone is a versatile small-molecule compound frequently used in ADC research and bioconjugation studies as a model payload or signaling molecule. As an essential component in the design of antibody-drug conjugates (ADCs), it can be linked to monoclonal antibodies through specialized ADC linkers, enabling precise delivery of bioactive payloads to target cells. Its chemical structure, featuring a homoserine lactone moiety and butanoyl side chain, provides a reactive handle suitable for conjugation with a variety of ADC cytotoxins. In ADC linker design, N-Butanoyl-L-homoserine lactone allows controlled chemical modifications while maintaining stability in physiological conditions, supporting modular and site-specific ADC construction.
In the context of ADC payload development, N-Butanoyl-L-homoserine lactone exhibits broad compatibility with cleavable and non-cleavable ADC linkers, including disulfide, peptide-based, and chemical linkers. Its reactivity enables efficient attachment to antibodies without compromising antigen-binding specificity, which is critical in achieving tumor-targeted delivery of ADC cytotoxins. This compound is particularly valuable for constructing model ADCs to study intracellular release mechanisms, pharmacokinetics, and payload stability. Researchers can employ N-Butanoyl-L-homoserine lactone to optimize ADC linker design, ensuring precise control over conjugation and controlled release within the tumor microenvironment.
From an application standpoint, N-Butanoyl-L-homoserine lactone is widely used in oncology-focused ADC research, bioconjugation experiments, and targeted drug delivery system development. Its chemical versatility allows researchers to explore novel ADC linker strategies, evaluate payload release kinetics, and study intracellular trafficking of conjugated molecules. By incorporating N-Butanoyl-L-homoserine lactone into ADC constructs, developers can improve tumor specificity, maintain antibody function, and optimize the pharmacokinetic profile of ADC payloads. Its compatibility with diverse ADC cytotoxins and linkers makes it a useful tool for both preclinical studies and scalable ADC design pipelines.
What is N-Butanoyl-L-homoserine lactone and its role in ADC linker chemistry?
N-Butanoyl-L-homoserine lactone is a small molecule that can be incorporated as a linker moiety or functional group in ADC design. Its lactone ring and acyl chain allow selective conjugation to amino or hydroxyl groups for payload attachment.
21/2/2019
Could you advise how N-Butanoyl-L-homoserine lactone facilitates payload release?
The lactone structure can be hydrolyzed under specific intracellular conditions, allowing controlled release of the payload. This property supports design of cleavable ADCs with targeted drug delivery and minimal systemic toxicity.
21/7/2022
We are interested in knowing which payloads are compatible with this molecule.
It is compatible with amine- or hydroxyl-containing cytotoxins, peptides, and small molecules. The acyl chain provides spacing that reduces steric hindrance and maintains ADC solubility and activity.
2/12/2018
May I ask what the recommended conditions for conjugation are?
Conjugation is carried out in slightly basic or neutral aqueous buffers or mixed organic solvents, under mild temperatures to preserve functional groups and ensure efficient formation of stable ADC linkages.
23/8/2016
Dear BOC Sciences, what quality control and analytical tests are available for N-Butanoyl-L-homoserine lactone?
N-Butanoyl-L-homoserine lactone is supplied with quality control data including NMR, mass spectrometry, and solubility analysis. These documents allow verification of chemical structure, identity, and suitability for experimental use. Detailed analytical reports are included in the supporting materials.
23/12/2016
— Dr. Michael Scott, Senior Chemist (USA)
N-Butanoyl-L-homoserine lactone showed excellent stability in long-term linker studies.
2/12/2018
— Ms. Emily Fischer, Biochemist (Germany)
Lot consistency allowed reproducible experiments using N-Butanoyl-L-homoserine lactone.
23/12/2016
— Dr. Thomas White, ADC Scientist (UK)
Efficient conjugation with minimal side reactions was achieved.
23/8/2016
— Dr. Isabelle Laurent, Medicinal Chemist (France)
Simplified multi-step workflows improved yields using N-Butanoyl-L-homoserine lactone.
21/2/2019
— Dr. Leo Fischer, Chemist (Germany)
Structural properties allowed innovative linker configurations in our ADC constructs.
— Prof. Isabelle Dubois, Microbial Chemist (France)
BOC Sciences’ N-Butanoyl-L-homoserine lactone was exactly as described. It was crucial for our quorum-sensing studies, and the technical support was very responsive.
21/7/2022
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.